9.17
+6.63%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Clearpoint Neuro
From its filings with the US Securities and Exchange Commission
Clearpoint Neuro is based in Solana Beach, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker CLPT. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $37.0m and a net loss of $25.5m. At that date it held total assets of $97.7m and shareholders' equity of $28.0m.
We are a commercial-stage medical device company, incorporated in 1998 as a Delaware corporation, that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. From our inception in 1998, we have deployed significant resources to fund our efforts to develop the foundational capabilities for enabling magnetic resonance imaging (“MRI”) guided interventions, building an intellectual property portfolio, and identifying and building out commercial applications for the technologies we develop. In 2021, our efforts expanded beyond the MRI suite to encompass development and commercialization of neurosurgical device products for the operating room setting, as well as consulting services for pharmaceutical companies.
In 2025, through our acquisition of IRRAS Holdings, Inc. (“IRRAS”), we expanded our portfolio into neurocritical care. IRRAS is a commercial-stage medical technology company focused on treatments for intracerebral hemorrhage, intraventricular hemorrhage, and other conditions requiring intracranial fluid management.
The IRRAS products complement our existing neurosurgical technologies and broaden our reach into acute care settings, enabling us to offer an expanded set of solutions spanning functional neurosurgery, neurocritical care, and intracranial drug delivery.
Quoted from its 10-K, filed 17 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 3 Jul 2019
- Employees
- 172
- Website
- clearpointneuro.com ↗
- Head office
- 120 S. SIERRA AVENUE, SOLANA BEACH, CA, 92075
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. R. John FletcherIndependent Chairman of the Board$227,199
- Mr. Joseph BurnettPresident, Chief Executive Officer, Director, since 2017$2.5m
- Mr. Danilo D' AlessandroChief Financial Officer$1.2m
- Mr. Mazin SabraChief Operating Officer
- Mr. Jeremy StigallChief Business Officer$1.1m
- Ms. Lynnette FallonIndependent Director$202,495
- Mr. Pascal GirinIndependent Director$188,412
- Ms. B. Kristine JohnsonIndependent Director$189,995
- Dr. Matthew KleinIndependent Director$174,995
- Dr. Linda LiauIndependent Director$182,339
- Mr. Timothy RichardsIndependent Director$193,957
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 38
- Environment
- 44
- Social
- 25
- Governance
- 46
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Clearpoint Neuro Inc. has several strengths that contribute to its competitive advantage in the market:
Weaknesses
- Despite its strengths, Clearpoint Neuro Inc. also faces certain weaknesses that may hinder its growth:
Opportunities
- Clearpoint Neuro Inc. can capitalize on the following opportunities to enhance its market position:
Threats
- Clearpoint Neuro Inc. should be aware of the following threats that may impact its business:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.